[Diagnosis of and therapy for hepatocellular carcinoma]

Zeitschrift Fur Gastroenterologie
|November 19, 2013
PubMed

Insights

These S3-level interdisciplinary guidelines offer evidence-based diagnosis and therapy strategies for hepatocellular carcinoma (HCC). They aim to improve patient care, quality of life, and reduce mortality for HCC patients.

Area of Science:

  • Hepatobiliary Medicine
  • Oncology
  • Evidence-Based Medicine

Context:

  • Hepatocellular carcinoma (HCC) diagnosis and therapy present significant challenges.
  • Existing healthcare practices require updated, evidence-based guidance.
  • Interdisciplinary collaboration is crucial for optimal HCC management.

Purpose:

  • To provide scientifically rigorous and current diagnostic and therapeutic procedures for HCC patients.
  • To guide management for all stages of HCC, including recurrent and metastatic disease.
  • To support healthcare professionals in advising patients on specialist procedures, side effects, and outcomes.

Summary:

  • The S3-level guidelines consolidate evidence and expert consensus for HCC management.
  • They detail procedures for diagnosis, therapy, and rehabilitation.
  • Explanatory texts facilitate informed patient consultations by non-specialists.

Impact:

  • Improvement in the diagnosis and treatment of hepatocellular carcinoma.
  • Foundation for personalized, high-quality HCC therapy.
  • Reduction in HCC-related morbidity and mortality, enhancing patient quality of life.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
893
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
30